Thromboxane B2

02/01/1994 - "Thromboxane B2 was monitored as index of inflammation. "
01/01/1993 - "As AP did not reduce the intensity of perivascular inflammation, reduced only slightly the proliferation of inflammatory cells, and did not affect the release of thromboxane B2 from the inflammatory macrophages, it is likely that the AP effect is not directed to the inflammatory cells. "
08/01/1978 - "(5) The possible role of thromboxane B2 in inflammation is discussed."
08/01/1990 - "The aim of the study was to compare two bleeding indexes, the Gingival Bleeding Index (GBI) and the Gingival Bleeding Time Index (BTI) in evaluating the intensity of inflammation in deep periodontal tissues measured by the level of thromboxane B2 in the tissues themselves. "
02/01/1993 - "Thromboxane B2 correlated best with presence of inflammation and necrosis. "

08/01/1998 - "The results of the present study demonstrated that the concentrations of thromboxane B2 (TxB2a) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), and their ratio were significantly increased in the medium of intra-pulmonary arteriolar smooth muscle cells (PASMCs) under acute hypoxia. "
03/01/1993 - "Thromboxane B2 concentration was increased in all the types of hypoxia. "
07/01/1993 - "However, thromboxane B2 could not be detected in samples from organ baths containing IMA segments without endothelium before or during hypoxia. "
11/01/1992 - "The results suggest that epidural anesthesia does not inhibit HPV, but exerts some effects on thromboxane B2 synthesis during alveolar hypoxia."
07/01/2001 - "At baseline, and during hypoxia at 20 min and 2 h, cardiac output (Q) was measured, PVR calculated and plasma levels of a prostacyclin metabolite (6-keto-PgF1alpha) and thromboxane B2 (TxB2) were measured. "

10/15/2019 - "The aim of this study was to address NOX-2 activity as well as serum thromboxane B2 (TXB2) and 8-isoPGF2-alpha in offspring of patients with premature myocardial infarction. "
04/01/1988 - "Platelet aggregation and thromboxane B2 release in patients with acute myocardial infarction--their relation to coronary patency."
06/01/1987 - "[Changes in circulatory thromboxane B2 and 6-keto-prostaglandin F1 alpha in acute myocardial infarction]."
11/01/1986 - "Immunoreactive thromboxane B2 (i-TXB2) was measured by radio-immunoassay (RIA) in urines collected over eight hours on the day of admission in 25 patients who were admitted with the diagnosis of myocardial infarction. "
07/01/1985 - "Twenty two of 31 patients who were admitted within 6 hr after the onset of acute myocardial infarction, exhibited high thromboxane B2 levels (greater than 300 pg/ml plasma) during the first 24 hr, whereas thromboxane B2 levels of 9 patients never exceeded 300 pg/ml during that period. "

06/01/1996 - "Thromboxane B2 levels were measured from blood samples obtained at pre-ischemia, and at 1 h and 48 h of reperfusion. "
08/01/1995 - "In nonrunners, however, thromboxane B2 was already elevated during ischemia (147 +/- 9%, P < .01) and remained elevated longer during recirculation (P < .05). "
01/01/1992 - "Thromboxane B2 levels were 2983 +/- 1083 pg/ml and 9483 +/- 2218 pg/ml at pre-ischemia and at one hour of reperfusion respectively (p less than 0.04). "
03/01/1991 - "Both thromboxane B2 and 6-keto-prostaglandin F1 alpha increased significantly during ischemia compared with preischemic values in all groups of hearts. "
01/01/1991 - "Blood samples were drawn from the renal vein before ischemia and after reperfusion to determine serum levels of thromboxane B2 (TxB2). "

11/01/1990 - "[Contents of 6-keto-prostaglandin F1 alpha and thromboxane B2 in the blood of patients with bronchial asthma]."
08/01/1990 - "[Changes in plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in bronchial asthma]."
11/01/2019 - "The patients with IL-17-high asthma were characterized by risk of frequent exacerbations, airway (sputum and mucosal) neutrophilia, decreased lung microbiota diversity, and urinary biomarker evidence of activation of the thromboxane B2 pathway. "
06/01/2000 - "Plasma concentration of thromboxane B2(TXB2) and 11-dehydro-TXB2(11-DH-TXB2) and P-selectin (CD 62P) on platelet surface were measured in 44 patients with asthma and in 18 normal individuals using ELISA and FCP. "
09/01/2000 - "The changes on symptoms and signs of asthma, pulmonary function, T-lymphocyte subsets, plasma soluble interleukin-2 receptor (sIL-2R), thromboxane B2(TXB2) and 6-keto-prostaglandin F1 alpha(6-keto-PGF1 alpha) were observed before and after treatment. "